Tactile Systems Technology, Inc. delivered robust financial results for the third quarter of 2025, with total revenue increasing 17% year-over-year to $85.8 million. The company saw a substantial rise in net income by 59% to $8.2 million and adjusted EBITDA by 34% to $14.4 million, reflecting effective business transformation and product innovation. Both lymphedema and airway clearance product lines contributed to this growth, and the company also repaid its term loan and authorized a new share repurchase program.
Tactile Systems Technology, Inc. delivered strong financial performance in the second quarter of 2025, with total revenue increasing by 7.8% year-over-year to $78.9 million, exceeding expectations. The growth was primarily driven by a significant increase in airway clearance product sales. Despite the revenue growth, net income and adjusted EBITDA saw declines compared to the prior year, attributed to planned strategic investments.
Tactile Medical reported a slight increase in total revenue for Q1 2025, up 0.3% year-over-year to $61.3 million. The company experienced a net loss of $3.0 million and an Adjusted EBITDA loss of $0.3 million, compared to a net loss of $2.2 million and positive Adjusted EBITDA of $1.0 million in the prior year quarter.
Tactile Systems Technology, Inc. delivered a strong performance in Q4 2024, with total revenue increasing by 10% year-over-year to $85.6 million. The company also saw an increase in gross margin to 75% and net income to $9.7 million, demonstrating consistent profitability and operational efficiency.
Tactile Systems Technology reported a 5% increase in total revenue to $73.1 million for Q3 2024. The company saw improvements in profitability and authorized a share repurchase program of up to $30 million.
Tactile Systems Technology, Inc. reported a 7% increase in total revenue to $73.2 million for the second quarter ended June 30, 2024, compared to $68.3 million in the second quarter of 2023. The company's net income was $4.3 million, a significant improvement from the net loss of $0.1 million in Q2 2023. Adjusted EBITDA also increased by 49% year-over-year to $9.1 million.
Tactile Systems Technology, Inc. reported a 4% increase in total revenue to $61.1 million for the first quarter of 2024, driven by a 5% increase in lymphedema product revenue. The company's net loss was $2.2 million, while adjusted EBITDA improved to $1.0 million.
Tactile Systems Technology, Inc. reported a 5% increase in total revenue to $77.7 million and a 77% increase in net income to $8.2 million for the fourth quarter of 2023. The company's performance was driven by growth in the lymphedema product line and overall progress in 2023.
Tactile Systems Technology, Inc. reported a 7% increase in revenue to $69.6 million, driven by a 15% increase in lymphedema product revenue. The company achieved a net income of $22.3 million, a significant improvement from the net loss of $2.3 million in the same quarter of the previous year. Improved salesforce productivity and operational efficiency contributed to record quarterly operating income and increased cash flow from operations.
Tactile Systems Technology, Inc. reported a 15% increase in revenue to $68.3 million for the second quarter of 2023. The company saw improvements in both GAAP and non-GAAP profitability. They are raising total revenue guidance based on strong performance in the first half of 2023.
Tactile Systems Technology reported a strong first quarter with a 23% increase in total revenue year-over-year, driven by growth in both Lymphedema and Airway clearance product lines. The company also saw significant improvements in operating margins on both a GAAP and non-GAAP basis. They raised full year 2023 outlook.
Tactile Systems Technology, Inc. reported a 20% increase in total revenue for Q4 2022, reaching $73.9 million compared to $61.7 million in Q4 2021. The company also saw improvements in profitability, with operating income increasing to $7.9 million and net income reaching $4.6 million, a significant turnaround from the net loss of $7.5 million in the same quarter of the previous year.
Tactile Systems Technology, Inc. reported a 24% increase in total revenue to $65.3 million for the third quarter of 2022, driven by growth in both airway clearance and lymphedema product lines. The company also delivered significant improvements in profitability, with increased gross, operating, and adjusted EBITDA margins.
Tactile Systems Technology, Inc. reported a 17% increase in revenue for the second quarter of 2022, driven by airway clearance product sales. However, the company experienced an operating loss and a net loss, compared to operating income and net income in the same quarter of the previous year.
Tactile Systems Technology, Inc. reported a 12% increase in first-quarter revenue, driven by sales of airway clearance products, specifically the AffloVest product line. However, the company experienced a significant increase in operating and net losses due to higher operating expenses, including non-cash intangible asset amortization and earn-out expenses related to the AffloVest acquisition.
Tactile Systems Technology, Inc. reported a 4% increase in revenue for the fourth quarter of 2021, reaching $61.7 million. This growth was primarily driven by the acquisition of AffloVest, which contributed $4.3 million in revenue. However, the company experienced a net loss of $7.5 million, compared to a net income of $12.1 million in the fourth quarter of 2020. The company introduced full year 2022 outlook.
Tactile Systems Technology reported a 7% increase in revenue for Q3 2021, reaching $52.5 million. However, the company experienced a net loss of $3.4 million, a decrease compared to the net income of $2.4 million in Q3 2020. The results were impacted by COVID-19, the Delta variant, and challenges in the labor market.
Tactile Systems Technology, Inc. reported a 45% increase in total revenue year-over-year, reaching $51.1 million. The company also reported a net income of $1.3 million, a significant improvement compared to the net loss of $13.9 million in the second quarter of 2020.
Tactile Systems Technology reported a 2% decrease in total revenue for Q1 2021, totaling $42.8 million compared to $43.7 million in Q1 2020. The company experienced a net loss of $2.3 million, an increase from the $1.3 million net loss in the same quarter last year. Despite these challenges, the company reaffirmed its full-year 2021 outlook, anticipating revenue growth approaching 20% in the second half of the year.
Tactile Systems Technology, Inc. reported a 4% year-over-year increase in fourth-quarter revenue, reaching $59.2 million, and net income of $12.1 million. The company exceeded the high end of its annual revenue guidance range, and is positioned to improve its coverage and the productivity of its representatives.
Tactile Systems Technology reported a slight decrease in revenue for Q3 2020, but net income remained the same as the previous year. The company's performance was impacted by the COVID-19 pandemic, but they were pleased with their strong execution in the third quarter.
Tactile Systems Technology reported a 22% decrease in total revenue for the second quarter of 2020, primarily due to the impact of the COVID-19 pandemic on healthcare facilities and patient access. The company experienced an operating loss of $8.0 million and a net loss of $13.9 million, which included a $4.0 million non-cash impairment charge. Despite these challenges, the company saw improving trends throughout the quarter and remains cautiously optimistic about the second half of the year.
Tactile Systems Technology reported a 16% increase in total revenue for Q1 2020, reaching $43.7 million. However, the company experienced an operating loss of $4.5 million and a net loss of $1.3 million, impacted by the COVID-19 pandemic and increased operating expenses.
Tactile Systems Technology, Inc. reported a 23% increase in revenue for the fourth quarter of 2019, reaching $57.1 million, driven by increased sales of Flexitouch and Entre systems. The company's operating income and net income also saw significant increases, and they anticipate continued growth and improved profitability in 2020.